ArticleOncotarget2017

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.

Nabanita Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.